Manage a Research Facility for the production and purification of proteins.Develop and maintain Laboratory safety and Quality systems.Develop methods and protocols to assist other research groups in achieving their goals.Operation of Applikon 5 and 30L fermenters, AKTA explorer, AKTA purifier, Shimadzu HPLC.Train students and academics in advanced protein purification laboratory techniques.

Media and condition screening for optimal secondary metabolite production from bacteria and fungi.Laboratory and Pilot scale fermentation of bacteria and fungi for the production of secondary metabolites.Selection and application of chromatographic techniques to purify secondary metabolites from fermentation streams.Sample preparation and Operation of HPLC for the analysis of samples for secondary metabolites.Method development and application of Preperative HPLC for the purification of secondary metabolites.

Worked on Eimeria vaccine trial vaccinating chickens, preparation of vaccines, immunization of chickens and measurement of immune response in the eggs, hatched chicks and took part in challenge trial to test vaccine efficacy. Antigen production and scale up for trials for larger trials.Expression of novel proteins for multiple projects using different expression systems, bacterial and yeast.Provide technical support for researchers trying to express proteins in various systems, and downstream purification processing. Helped IBID develop basic QA systems to help them meet required QA levels for continued funding.Involved in relocation of research labs from Gore Hill to city, setup and management of new lab facilities. Management of various lab equipment and lab suites, currently maintaining and training users in High Speed Centrifuge facility, Sonicator and freeze drier.

New Vaccine development for Australian and International Markets based on improved technology.Development of new Downstream technologies for processing of large scale Clostridial fermentation products.Involved with development of new media to help comply with changed regulations due to BSE and a move from meat based media. Transfer of technology from the development labs into the production envelope to improve vaccine manufacture and vaccine performance. Involved in the development of new multivalent Clostridial vaccines for the international markets.

Production of ELISA for the detection of T.cruzii, purification and conjugation of antibodies to fluorescence isothiocyante for IFA kits. QC/QA test kits.